Today, Rowan is proud to announce our latest game-changing feature—glitch mode. Glitch mode makes it possible for your molecular visualizations to look super cyberpunk (think Neuromancer or Blade Runner).

When Ilya Sutskever once explained why next-word prediction leads to intelligence, he made a metaphor: if you can piece together the clues and deduce the criminal’s name on the last page, you have a real understanding of the story. 🕵️‍♂️ Inspired by that idea, we turned to Ace

I've come up with a way of demystifying e (2.718) for high schoolers. poshenloh.com/e I think it is much more intuitive than how e is currently taught, and could update all of the textbooks. Full article: arxiv.org/abs/2504.10664 In the USA, the first time people learn

Today, we are launching the first publicly available AI Scientist, via the FutureHouse Platform. Our AI Scientist agents can perform a wide variety of scientific tasks better than humans. By chaining them together, we've already started to discover new biology really fast. With

Speaking for myself Futurehouse Falcon FutureHouse is too good that I actually start to feel scared

Jfc make it stop. It’s 2025. I wonder if total sales of CRISPR products from these patents ever surpasses the fees the lawyers took battling it out in court.

Excited to share our new Science Magazine paper! Led by postdocs Ruchao Peng and Xin Xu, we used cryo-EM/ET to reveal the influenza ribonucleoprotein complex structure and its strand-sliding mechanism for RNA synthesis, paving the way for new antivirals. science.org/doi/10.1126/sc…

My lab is recruiting a postdoc fellow to characterize new biochemical pathways that control taurine and glucose metabolism. Email me at [email protected] to apply! Please help RT🙏 Long Lab Judith Simcox PhD UW–Madison Biochem

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

An attempt to explain (current) ChatGPT versions. I still run into many, many people who don't know that: - o3 is the obvious best thing for important/hard things. It is a reasoning model that is much stronger than 4o and if you are using ChatGPT professionally and not using o3

Most interesting part of the Boltz-2 paper was how important curation was to achieve competitive results with FEP As we move "upwards" from molecular interactions to more complex disease mechanisms - pathway dynamics, cell-cell interactions, whole tissue biomarkers - think about

Setting up a lab has been no joke. Today, I'm stoked to have one more piece of my postdoc work out in the wild. Several more manuscripts to go, and I don't have a lot of time for a tweetorial today, but enjoy and happy to get any feedback on this story. biorxiv.org/content/10.110…

Joshua Zahl全职入职南开大学 （大陆给出的offer是真的猛） 因证明了三维挂谷猜想而备受世界瞩目的国际知名数学学者Joshua Zahl正式入职南开大学陈省身数学研究所，全职受聘为讲席教授。6月23日上午，南开大学校长陈雨露会见了Joshua Zahl教授。副校长白承铭一同参加会见。

lol, amateurs. And that's without my 5y of DotA Allstars (v1)

Core Investigator Lingyin Li, PhD's new paper in @NatChemBio investigates why human STING inhibitors have shown limited efficacy, despite strong activity in mouse models. The study, led by X Cao and Rebecca Chan, finds that the commonly targeted site on STING is not required for

To the 23andMe Community, I am incredibly excited and humbled to share with you that TTAM Research Institute (TTAM), a new non—profit medical research organization that I founded and lead, has completed the acquisition of 23andMe.   I formed TTAM and pursued the acquisition of

We might be heading into a plot twist in the OpenAI vs. DeepMind IMO saga. Just saw a post from Joseph Myers (involved in the Math Olympiad since 1992): the IMO committee reportedly asked AI labs not to publish results until 7 days after the closing ceremony — out of respect for

Protein structure prediction contest CASP gets temporary funding from Google DeepMind as NIH grant runs out. trib.al/bGoz7lf

Deepseek just released a new model! huggingface.co/deepseek-ai/De…

A NOA from NIDA on a UG3 grant is here. Excited to work with Brian Kobilka and Jay Mclaughlin on NAMs for treating opioid overdose upto IND phase. Several postdoc positions in both chemistry/pharmacology available. WashU Medicine Center for Clinical Pharmacology Please RT